LISATA THERAPEUTICS, INC.: directors' dealings · United States · SEC (Form 4) Explore the full management transaction log of LISATA THERAPEUTICS, INC., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 13 January 2026 (Attribution). Among the most active insiders: Buck Kristen K. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 13 January 2026
All Executives39 Thresholds0 Prospectus0 Other0
Declarations 39 total
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001373585-26-000003:0
◆ Director · Executives · 9 Jan 2026
30,456 shares 0Common Stock SEC:0001309653-26-000004:0
◆ EVP, R&D and CMO · Executives · 9 Jan 2026
25,000 shares 0Common Stock SEC:0001879231-26-000003:0
● EVP, R&D and CMO · Executives · 9 Jan 2026
2,982 shares @ US$1.97 7.8% of flow Common Stock SEC:0001879231-26-000003:1
● EVP, R&D and CMO · Executives · 9 Jan 2026
2,982 shares @ US$1.97 7.8% of flow Common Stock SEC:0001879231-26-000003:2
● EVP, R&D and CMO · Executives · 9 Jan 2026
3,221 shares @ US$1.97 8.4% of flow Common Stock SEC:0001879231-26-000003:3
● EVP, R&D and CMO · Executives · 9 Jan 2026
2,147 shares @ US$1.97 5.6% of flow Common Stock SEC:0001879231-26-000003:4
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001283301-25-000002:0
◆ EVP, R&D and CMO · Executives · 9 Jan 2025
25,000 shares 0Common Stock SEC:0001879231-25-000002:0
◆ SVP, Fin/Treas, Chief Actg Off · Executives · 9 Jan 2025
15,000 shares 0Common Stock SEC:0002020260-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001741455-25-000002:0
◆ President & CEO · Executives · 9 Jan 2025
81,000 shares 0Common Stock SEC:0001334549-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001373585-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001309653-25-000002:0
◆ Director · Executives · 9 Jan 2025
15,789 shares 0Common Stock SEC:0001192621-25-000002:0
◆ EVP, R&D and CMO · Executives · 1 Oct 2024
15,000 shares @ US$2.93 61.4% of flow Common Stock SEC:0001879231-24-000004:0
◆ President & CEO · Executives · 1 Oct 2024
58,000 shares @ US$2.93 95.5% of flow Common Stock SEC:0001334549-24-000006:0
◆ SVP, Fin/Treas, Chief Actg Off · Executives · 1 Oct 2024
3,300 shares @ US$2.93 100.0% of flow Common Stock SEC:0002020260-24-000002:0
● Chief Executive Officer · Executives · 11 Jan 2024
1,026 shares @ US$2.99 1.7% of flow Common Stock SEC:0001334549-24-000004:0
◆ Director · Executives · 9 Jan 2024
19,480 shares 0Common Stock SEC:0001192621-24-000003:0
◆ Director · Executives · 9 Jan 2024
19,480 shares 0Common Stock SEC:0001309653-24-000002:0
◆ Director · Executives · 9 Jan 2024
19,480 shares 0Common Stock SEC:0001741455-24-000002:0
◆ Director · Executives · 9 Jan 2024
19,480 shares 0Common Stock SEC:0001373585-24-000002:0
◆ Chief Executive Officer · Executives · 9 Jan 2024
94,000 shares 0Common Stock SEC:0001334549-24-000002:0
◆ EVP, R&D and CMO · Executives · 9 Jan 2024
27,000 shares 0Common Stock SEC:0001879231-24-000002:0
25 of 39 declarations
Load more (14 remaining)